172 material Form 8-K filings that 152 companies we cover made with the SEC in September 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Roivant's subsidiary Dermavant agreed on September 17, 2024 to be acquired by Organon for up to about $1.2 billion, including a $175 million payment at closing, a $75 million milestone on FDA approval of VTAMA for atopic dermatitis, and up to $950 million in sales-based milestones, plus tiered royalties. Roivant owns about 87% of Dermavant's shares, so the deal would deliver most of the proceeds to Roivant, though the amount depends on future milestones and the closing is subject to conditions.
Organon agreed to acquire Dermavant for up to about $1.2 billion in aggregate cash consideration, including a $175 million payment at closing
Additional $75 million payable on FDA approval of VTAMA for atopic dermatitis, and up to $950 million in tiered net sales milestones
Roivant owns approximately 87% of Dermavant's common and preference shares; shareholder written consent of at least 75% of voting rights was obtained
Expected to close in the fourth quarter of 2024; either party may terminate if not closed by March 17, 2025
Horace Mann Educators named Ryan Greenier, currently Deputy CFO, as Executive Vice President and Chief Financial Officer, effective October 1, 2024, succeeding Bret Conklin, who plans to retire after remaining with the company through 2025. The filing also discloses a letter agreement under which CEO Marita Zuraitis's equity awards will fully vest upon separation or retirement if she stays through December 31, 2027, and bylaw amendments that add a stockholder advance notice requirement first applicable to the 2025 annual meeting.
Ryan Greenier, 42, becomes CFO effective October 1, 2024; his annual salary is $350,000 with an AIP target of 50% of eligible earnings and an LTIP target of $275,000.
Bret Conklin will remain through 2025 and serve as Executive Vice President, Finance Transformation.
CEO Marita Zuraitis's agreement, dated September 17, 2024, provides full vesting of equity awards at separation or retirement; it adds no incremental awards.
Advance notice window for 2025 annual meeting nominations: January 22, 2025 to February 21, 2025.
Q2 Holdings said its board appointed Jonathan A. Price, currently executive vice president of strategy and emerging businesses, as chief financial officer effective on or about November 6, 2024. He succeeds David J. Mehok, who is departing the company but will remain CFO through that date to assist with an orderly transition. The filing says Mehok's departure is not due to any dispute with Q2 over its operations, policies, practices or financial performance.
Price, 41, will become CFO and principal financial and accounting officer after Q2 files its Form 10-Q for the period ended September 30, 2024
Mehok will receive an incremental transition bonus of $90,000, payable over the 18 months after his departure, subject to his service through the transition date
No changes were made to Price's compensation or his employment agreement dated February 17, 2024
Responsibility for emerging businesses operations will transfer to Kirk Coleman, Q2's President
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.